Skip to content
10-Q

Quarterly Report

HAEMONETICS CORPORATION HAE

0000313143-26-000010

← back to feed
Filed
Feb 5, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Jan 30, 2026 46.47M sh
Shares Diluted Q3 2026 · Dec 27, 2025 46.99M sh
Shares Diluted Q3 2026 · Dec 27, 2025 47.67M sh
Shares Diluted Q3 2026 · Dec 28, 2024 50.64M sh
Shares Diluted Q3 2026 · Dec 28, 2024 51.15M sh
Stock Repurchased Q3 2026 · Dec 27, 2025 $75M
Stock Repurchased Q3 2026 · Dec 28, 2024 $75M
Capex Q3 2026 · Dec 27, 2025 $15.12M
Capex Q3 2026 · Dec 28, 2024 $23.64M
Operating Cash Flow Q3 2026 · Dec 27, 2025 $222.28M
Operating Cash Flow Q3 2026 · Dec 28, 2024 $65.17M
Long Term Debt Q3 2026 · Dec 27, 2025 $919.99M
Long Term Debt Q3 2026 · Mar 29, 2025 $921.23M
Cash And Equivalents Q3 2026 · Dec 27, 2025 $363.37M
Cash And Equivalents Q3 2026 · Mar 29, 2025 $306.76M
Stockholders Equity Q3 2026 · Dec 27, 2025 $911.45M
Stockholders Equity Q3 2026 · Sep 27, 2025 $849.17M
Stockholders Equity Q3 2026 · Jun 28, 2025 $882.3M
Stockholders Equity Q3 2026 · Mar 29, 2025 $820.84M
Stockholders Equity Q3 2026 · Dec 28, 2024 $906.86M
Stockholders Equity Q3 2026 · Sep 28, 2024 $878.85M
Stockholders Equity Q3 2026 · Jun 29, 2024 $905.37M
Stockholders Equity Q3 2026 · Mar 30, 2024 $959.96M
Current Liabilities Q3 2026 · Dec 27, 2025 $539.87M
Current Liabilities Q3 2026 · Mar 29, 2025 $578.11M
Current Assets Q3 2026 · Dec 27, 2025 $943.67M
Current Assets Q3 2026 · Mar 29, 2025 $934.98M
Total Assets Q3 2026 · Dec 27, 2025 $2.49B
Total Assets Q3 2026 · Mar 29, 2025 $2.45B
Eps Diluted Q3 2026 · Dec 27, 2025 $0.95
Eps Diluted Q3 2026 · Dec 27, 2025 $2.46
Eps Diluted Q3 2026 · Dec 28, 2024 $0.74
Eps Diluted Q3 2026 · Dec 28, 2024 $2.14
Eps Basic Q3 2026 · Dec 27, 2025 $0.96
Eps Basic Q3 2026 · Dec 27, 2025 $2.47
Eps Basic Q3 2026 · Dec 28, 2024 $0.75
Eps Basic Q3 2026 · Dec 28, 2024 $2.16
Sga Expense Q3 2026 · Dec 27, 2025 $109.15M
Sga Expense Q3 2026 · Dec 27, 2025 $321.49M
Sga Expense Q3 2026 · Dec 28, 2024 $106.46M
Sga Expense Q3 2026 · Dec 28, 2024 $321.65M
Rd Expense Q3 2026 · Dec 27, 2025 $14.19M
Rd Expense Q3 2026 · Dec 27, 2025 $45.32M
Rd Expense Q3 2026 · Dec 28, 2024 $15.83M
Rd Expense restated Q3 2026 · Dec 28, 2024 $44.42M
Net Income Q3 2026 · Dec 27, 2025 $44.74M
Net Income Q3 2026 · Dec 27, 2025 $117.46M
Net Income Q3 2026 · Sep 27, 2025 $38.68M
Net Income Q3 2026 · Jun 28, 2025 $34.03M
Net Income Q3 2026 · Dec 28, 2024 $37.49M
Net Income Q3 2026 · Dec 28, 2024 $109.7M
Net Income Q3 2026 · Sep 28, 2024 $33.83M
Net Income Q3 2026 · Jun 29, 2024 $38.37M
Operating Income Q3 2026 · Dec 27, 2025 $67.4M
Operating Income Q3 2026 · Dec 27, 2025 $179.76M
Operating Income Q3 2026 · Dec 28, 2024 $59.03M
Operating Income Q3 2026 · Dec 28, 2024 $150.48M
Gross Profit Q3 2026 · Dec 27, 2025 $202.39M
Gross Profit Q3 2026 · Dec 27, 2025 $589.37M
Gross Profit Q3 2026 · Dec 28, 2024 $193.55M
Gross Profit Q3 2026 · Dec 28, 2024 $555.91M
Cost Of Revenue Q3 2026 · Dec 27, 2025 $136.58M
Cost Of Revenue Q3 2026 · Dec 27, 2025 $398.3M
Cost Of Revenue Q3 2026 · Dec 28, 2024 $155M
Cost Of Revenue Q3 2026 · Dec 28, 2024 $474.32M
Revenue Q3 2026 · Dec 27, 2025 $338.97M
Revenue Q3 2026 · Dec 27, 2025 $987.68M
Revenue Q3 2026 · Dec 28, 2024 $348.54M
Revenue Q3 2026 · Dec 28, 2024 $1.03B